Taiwan Biomaterial Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	179.17	220.4	96.57	72.84	127.31	41.67
Revenue Growth (YoY)	23.12%	128.22%	32.59%	-42.79%	205.48%	130.56%
Cost of Revenue	75.66	85.61	39.27	25.72	36.94	9.52
Gross Profit	103.5	134.8	57.31	47.12	90.37	32.15
Selling, General & Admin	51.73	50.41	37.46	38.57	32.79	23.46
Research & Development	25.14	23.55	31.08	22.78	32.12	65.41
Operating Expenses	76.87	73.96	68.54	61.35	64.91	88.87
Operating Income	26.64	60.83	-11.24	-14.23	25.46	-56.72
Interest Expense	-0.73	-0.74	-0.8	-0.87	-0.97	-1.03
Interest & Investment Income	5.41	5.38	3.84	4.7	2.25	0.49
Currency Exchange Gain (Loss)	-6.89	-6.89	3.67	0.27	6.67	-0.63
Other Non Operating Income (Expenses)	1.6	0.35	0.78	1.1	0.34	10.48
EBT Excluding Unusual Items	26.02	58.93	-3.75	-9.03	33.76	-47.4
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0.04
Pretax Income	26.02	58.93	-2.49	-9.03	33.76	-47.44
Income Tax Expense	-	-	-0.76	1.1	-	-
Net Income	26.02	58.93	-1.73	-10.13	33.76	-47.44
Net Income to Common	26.02	58.93	-1.73	-10.13	33.76	-47.44
Shares Outstanding (Basic)	42	42	42	42	41	33
Shares Outstanding (Diluted)	42	42	42	42	41	33
Shares Change (YoY)	-0.01%	-	-	2.73%	23.90%	-
EPS (Basic)	0.62	1.40	-0.04	-0.24	0.83	-1.44
EPS (Diluted)	0.62	1.40	-0.04	-0.24	0.83	-1.44
Free Cash Flow	15.16	47.33	14.74	-12.74	-6.36	-54.3
Free Cash Flow Per Share	0.36	1.13	0.35	-0.30	-0.16	-1.65
Dividend Per Share	-	1.000	-	-	0.200	-
Gross Margin	57.77%	61.16%	59.34%	64.69%	70.99%	77.15%
Operating Margin	14.87%	27.60%	-11.63%	-19.53%	20.00%	-136.10%
Profit Margin	14.52%	26.74%	-1.79%	-13.91%	26.52%	-113.84%
Free Cash Flow Margin	8.46%	21.47%	15.26%	-17.49%	-5.00%	-130.31%
EBITDA	37.49	71.97	0.99	-2.28	36.02	-51.8
EBITDA Margin	20.92%	32.65%	1.03%	-3.14%	28.29%	-124.29%
D&A For EBITDA	10.85	11.14	12.23	11.94	10.55	4.92
EBIT	26.64	60.83	-11.24	-14.23	25.46	-56.72
EBIT Margin	14.87%	27.60%	-11.63%	-19.53%	20.00%	-136.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.